These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Invasive cervical cancer and intrauterine device use. Lassise DL; Savitz DA; Hamman RF; Barón AE; Brinton LA; Levines RS Int J Epidemiol; 1991 Dec; 20(4):865-70. PubMed ID: 1800424 [TBL] [Abstract][Full Text] [Related]
7. Intrauterine devices: an effective alternative to oral hormonal contraception. Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436 [TBL] [Abstract][Full Text] [Related]
8. Intrauterine device use and risk of tubal pregnancy: an Indonesian case-control study. Basuki B; Rossing MA; Daling JR Int J Epidemiol; 1994 Oct; 23(5):1000-5. PubMed ID: 7860150 [TBL] [Abstract][Full Text] [Related]
9. Intrauterine device use and the risk of pre-eclampsia: a case-control study. Parker SE; Jick SS; Werler MM BJOG; 2016 Apr; 123(5):788-95. PubMed ID: 25854682 [TBL] [Abstract][Full Text] [Related]
10. Risk factors for extrauterine pregnancy in women using an intrauterine device. Bouyer J; Rachou E; Germain E; Fernandez H; Coste J; Pouly JL; Job-Spira N Fertil Steril; 2000 Nov; 74(5):899-908. PubMed ID: 11056230 [TBL] [Abstract][Full Text] [Related]
11. Chlamydial serologic characteristics among intrauterine contraceptive device users: does copper inhibit chlamydial infection in the female genital tract? Mehanna MT; Rizk MA; Ramadan M; Schachter J Am J Obstet Gynecol; 1994 Sep; 171(3):691-3. PubMed ID: 8092216 [TBL] [Abstract][Full Text] [Related]
12. Was the Dalkon Shield a safe and effective intrauterine device? The conflict between case-control and clinical trial study findings. Mumford SD; Kessel E Fertil Steril; 1992 Jun; 57(6):1151-76. PubMed ID: 1601137 [TBL] [Abstract][Full Text] [Related]
13. A prospective study of some aetiological factors in limb reduction defects in Sweden. Källén B J Epidemiol Community Health; 1989 Mar; 43(1):86-91. PubMed ID: 2592897 [TBL] [Abstract][Full Text] [Related]
14. Intrauterine device use and endometrial cancer risk. Sturgeon SR; Brinton LA; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD; Lurain JR Int J Epidemiol; 1997 Jun; 26(3):496-500. PubMed ID: 9222773 [TBL] [Abstract][Full Text] [Related]
15. A multinational case-control study of ectopic pregnancy. The World Health Organization's Special Programme of Research, Development and Research Training in Human Reproduction: Task Force on Intrauterine Devices for Fertility Regulation. Clin Reprod Fertil; 1985 Jun; 3(2):131-43. PubMed ID: 4052920 [TBL] [Abstract][Full Text] [Related]
16. Teratogenic hazards of oral contraceptives analyzed in a national malformation register. Savolainen E; Saksela E; Saxén L Am J Obstet Gynecol; 1981 Jul; 140(5):521-4. PubMed ID: 7246686 [TBL] [Abstract][Full Text] [Related]
17. Contraception and the etiology of pelvic inflammatory disease: new perspectives. Senanayake P; Kramer DG Am J Obstet Gynecol; 1980 Dec; 138(7 Pt 2):852-60. PubMed ID: 7008602 [TBL] [Abstract][Full Text] [Related]
18. Frequency of non-hormonal contraception around conception and association with congenital malformations in offspring. Bracken MB; Vita K Am J Epidemiol; 1983 Mar; 117(3):281-91. PubMed ID: 6829556 [TBL] [Abstract][Full Text] [Related]
19. Residues of pelvic inflammatory disease in intrauterine device users: a result of the intrauterine device or Chlamydia trachomatis infection? Guderian AM; Trobough GE Am J Obstet Gynecol; 1986 Mar; 154(3):497-503. PubMed ID: 3513579 [TBL] [Abstract][Full Text] [Related]
20. Discontinued use of intrauterine contraceptive device and pregnancy loss. Levin AA; O'Shea M; Schoenbaum SC; Monson RR; Stubblefield PG; Ryan KJ Am J Obstet Gynecol; 1984 Aug; 149(7):768-71. PubMed ID: 6465229 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]